![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PLSCR4 |
Gene summary for PLSCR4 |
![]() |
Gene information | Species | Human | Gene symbol | PLSCR4 | Gene ID | 57088 |
Gene name | phospholipid scramblase 4 | |
Gene Alias | TRA1 | |
Cytomap | 3q24 | |
Gene Type | protein-coding | GO ID | GO:0002237 | UniProtAcc | Q9NRQ2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
57088 | PLSCR4 | LZE8T | Human | Esophagus | ESCC | 1.59e-03 | -6.62e-03 | 0.067 |
57088 | PLSCR4 | P1T-E | Human | Esophagus | ESCC | 9.76e-05 | 1.33e-01 | 0.0875 |
57088 | PLSCR4 | P2T-E | Human | Esophagus | ESCC | 1.16e-24 | 3.66e-01 | 0.1177 |
57088 | PLSCR4 | P5T-E | Human | Esophagus | ESCC | 6.08e-03 | 4.40e-02 | 0.1327 |
57088 | PLSCR4 | P8T-E | Human | Esophagus | ESCC | 7.03e-16 | 2.64e-01 | 0.0889 |
57088 | PLSCR4 | P9T-E | Human | Esophagus | ESCC | 6.06e-08 | 1.34e-01 | 0.1131 |
57088 | PLSCR4 | P10T-E | Human | Esophagus | ESCC | 1.29e-11 | 1.17e-01 | 0.116 |
57088 | PLSCR4 | P11T-E | Human | Esophagus | ESCC | 3.17e-03 | 3.76e-01 | 0.1426 |
57088 | PLSCR4 | P12T-E | Human | Esophagus | ESCC | 3.04e-05 | 1.70e-02 | 0.1122 |
57088 | PLSCR4 | P15T-E | Human | Esophagus | ESCC | 2.20e-09 | 1.25e-02 | 0.1149 |
57088 | PLSCR4 | P16T-E | Human | Esophagus | ESCC | 7.35e-03 | -7.12e-02 | 0.1153 |
57088 | PLSCR4 | P20T-E | Human | Esophagus | ESCC | 1.05e-23 | 8.06e-01 | 0.1124 |
57088 | PLSCR4 | P21T-E | Human | Esophagus | ESCC | 2.44e-03 | -1.06e-01 | 0.1617 |
57088 | PLSCR4 | P22T-E | Human | Esophagus | ESCC | 1.01e-05 | -6.01e-02 | 0.1236 |
57088 | PLSCR4 | P23T-E | Human | Esophagus | ESCC | 6.70e-04 | 4.25e-01 | 0.108 |
57088 | PLSCR4 | P24T-E | Human | Esophagus | ESCC | 1.58e-08 | 4.21e-02 | 0.1287 |
57088 | PLSCR4 | P26T-E | Human | Esophagus | ESCC | 6.82e-06 | -9.15e-02 | 0.1276 |
57088 | PLSCR4 | P27T-E | Human | Esophagus | ESCC | 2.15e-14 | 3.85e-02 | 0.1055 |
57088 | PLSCR4 | P28T-E | Human | Esophagus | ESCC | 9.24e-06 | 1.61e-02 | 0.1149 |
57088 | PLSCR4 | P30T-E | Human | Esophagus | ESCC | 2.02e-07 | 3.21e-01 | 0.137 |
Page: 1 2 3 |
![]() |
Tissue | Expression Dynamics | Abbreviation |
Esophagus | ![]() | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias | ||
LGIN: Low-grade intraepithelial neoplasias |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003249619 | Esophagus | ESCC | response to lipopolysaccharide | 191/8552 | 343/18723 | 1.11e-04 | 7.73e-04 | 191 |
GO:000223719 | Esophagus | ESCC | response to molecule of bacterial origin | 194/8552 | 363/18723 | 1.64e-03 | 7.61e-03 | 194 |
GO:007122215 | Esophagus | ESCC | cellular response to lipopolysaccharide | 113/8552 | 209/18723 | 8.79e-03 | 3.10e-02 | 113 |
GO:007121617 | Esophagus | ESCC | cellular response to biotic stimulus | 131/8552 | 246/18723 | 9.85e-03 | 3.39e-02 | 131 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PLSCR4 | SNV | Missense_Mutation | novel | c.104C>T | p.Ser35Phe | p.S35F | Q9NRQ2 | protein_coding | deleterious(0.03) | benign(0.365) | TCGA-E6-A1LX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PLSCR4 | SNV | Missense_Mutation | novel | c.600C>A | p.Phe200Leu | p.F200L | Q9NRQ2 | protein_coding | deleterious(0.03) | possibly_damaging(0.87) | TCGA-EY-A1GD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PLSCR4 | SNV | Missense_Mutation | c.142N>T | p.Pro48Ser | p.P48S | Q9NRQ2 | protein_coding | tolerated(0.07) | benign(0.037) | TCGA-ED-A7PZ-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
PLSCR4 | SNV | Missense_Mutation | c.914N>T | p.Lys305Ile | p.K305I | Q9NRQ2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-05-4410-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
PLSCR4 | SNV | Missense_Mutation | c.430N>T | p.Asp144Tyr | p.D144Y | Q9NRQ2 | protein_coding | deleterious(0) | probably_damaging(0.93) | TCGA-05-5428-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | cisplatin | CR | |
PLSCR4 | SNV | Missense_Mutation | novel | c.32N>T | p.Gln11Leu | p.Q11L | Q9NRQ2 | protein_coding | tolerated(0.09) | benign(0.035) | TCGA-55-7911-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
PLSCR4 | SNV | Missense_Mutation | c.742G>C | p.Gly248Arg | p.G248R | Q9NRQ2 | protein_coding | deleterious(0) | probably_damaging(0.998) | TCGA-55-A490-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Chemotherapy | carboplatin | SD | |
PLSCR4 | SNV | Missense_Mutation | novel | c.428A>C | p.Tyr143Ser | p.Y143S | Q9NRQ2 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-73-A9RS-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Chemotherapy | carboplatin | PD |
PLSCR4 | SNV | Missense_Mutation | c.278N>T | p.Gln93Leu | p.Q93L | Q9NRQ2 | protein_coding | tolerated(0.19) | benign(0.081) | TCGA-22-5492-01 | Lung | lung squamous cell carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
PLSCR4 | SNV | Missense_Mutation | rs768132771 | c.898C>A | p.Leu300Met | p.L300M | Q9NRQ2 | protein_coding | deleterious(0.05) | benign(0.269) | TCGA-34-5241-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |